Evidence map›Paper›PMID 26125594›Full record

ArticleNature methods2015

Pathway and network analysis of cancer genomes.

Pau Creixell, Jüri Reimand, Syed Haider, Guanming Wu, Tatsuhiro Shibata, Miguel Vazquez, Ville Mustonen, Abel Gonzalez-Perez, John Pearson, Chris Sander and 11 more

Abstract read
In one paragraph

Article in Nature methods, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 186 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
186citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

186 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. In Silico Analysis of Squamous Cell Carcinoma.Advances in experimental medicine and biology · 2026
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Proteomics appending a complementary dimension to precision oncotherapy.Computational and structural biotechnology journal · 2024
    Review
  17. Article
  18. Review
  19. Review
  20. Article

126 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Pau Creixell *Cellular Signal Integration Group (C-SIG), Technical University of Denmark, Lyngby, Denmark.
Jüri Reimand *The Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
Syed HaiderInformatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Guanming WuInformatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Tatsuhiro ShibataDivision of Cancer Genomics, National Cancer Center, Chuo-ku, Tokyo, Japan.
Miguel VazquezStructural Biology and Biocomputing Programme, Spanish National Cancer Research Centre, Madrid, Spain.
Ville MustonenWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
Abel Gonzalez-PerezResearch Unit on Biomedical Informatics, University Pompeu Fabra, Barcelona, Spain.
John PearsonQueensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, St. Lucia, Brisbane, Queensland, Australia.
Chris SanderComputational Biology Center, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Benjamin J RaphaelDepartment of Computer Science and Center for Computational Molecular Biology, Brown University, Providence, RI, USA.
Debora S MarksDepartment of Systems Biology, Harvard Medical School, Boston, MA USA.
B F Francis OuelletteInformatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Alfonso ValenciaStructural Biology and Biocomputing Programme, Spanish National Cancer Research Centre, Madrid, Spain.
Gary D BaderThe Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
Paul C BoutrosInformatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Joshua M StuartDepartment of Biomolecular Engineering, University of California, Santa Cruz, California, USA.
Rune LindingCellular Signal Integration Group (C-SIG), Technical University of Denmark, Lyngby, Denmark.
Nuria Lopez-BigasResearch Unit on Biomedical Informatics, University Pompeu Fabra, Barcelona, Spain.
Lincoln D SteinInformatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Mutation Consequences and Pathway Analysis Working Group of the International Cancer Genome Consortium

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
TR&D 3 - Network Guided Machine LearningP41GM103504 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IDEKER, TREY · 2012 to 2024
$17.3M
UCSC-Buck Inst. Genome Data Analysis Center for TCGA Research Network (GDAC)U24CA143858 · NCI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI BENZ, CHRISTOPHER, HAUSSLER, DAVID H · 2009 to 2016
$8.9M
Reactome: An Open Knowledgebase of Human PathwaysP41HG003751 · NHGRI · ONTARIO INSTITUTE FOR CANCER RESEARCH · PI STEIN, LINCOLN D. · 2007 to 2011
$4.5M
BIGDATA: Mid-Scale DCM: DA: ESCE: Discovering Molecular ProcessesR01CA180778 · NCI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI STUART, JOSHUA MICHAEL · 2013 to 2017
$3.5M
New Integrative Pathway Analysis Methods to Predict Biomedical OutcomesR01GM109031 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI STUART, JOSHUA MICHAEL · 2014 to 2018
$2.9M
Computational Characterization of Genetic HeterogeneityR01HG007069 · NHGRI · PRINCETON UNIVERSITY · PI RAPHAEL, BENJAMIN · 2013 to 2015
$1.1M
Canadian Institutes of Health ResearchNCI NIH HHS P30 CA008748NCI NIH HHS R01 CA180778NCI NIH HHS R01-CA180778NCI NIH HHS U24 CA143858NCI NIH HHS U24-CA143858NHGRI NIH HHS P41 HG003751NHGRI NIH HHS R01 HG007069NIGMS NIH HHS P41 GM103504NIGMS NIH HHS R01 GM109031
6 · The paper itself

Abstract

Genomic information on tumors from 50 cancer types cataloged by the International Cancer Genome Consortium (ICGC) shows that only a few well-studied driver genes are frequently mutated, in contrast to many infrequently mutated genes that may also contribute to tumor biology. Hence there has been large interest in developing pathway and network analysis methods that group genes and illuminate the processes involved. We provide an overview of these analysis techniques and show where they guide mechanistic and translational investigations.

Indexed as

Gene Regulatory NetworksGenomeHumansNeoplasmsSignal Transduction

Identifiers

PMID26125594
PMCPMC4717906

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.